Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07073599

Increasing Midwifery Students' Awareness of Breast and Gynecological Cancers Using Creative Drama Method

The aim of this study is to raise awareness among midwifery students, who are a part of the female population and a professional group that plays a critical role in the early diagnosis of these types of cancer, which are of critical importance for women's health, through an active education method such as drama.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Creative Drama

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Ataturk University Faculty of Health Sciences

Erzurum, Center, 25000, Turkey (Türkiye)

Location contact

Zülbiye DEMİR BARBAK, LECTURER

CONTACT

[email protected]

05435164229

About this study

The study will involve 50 volunteer midwifery students between the ages of 18 and 35 studying at the Faculty of Health Sciences. Students will be randomized and assigned to experimental and control groups. Awareness levels of breast and gynecological cancers in both groups will be determined. Students in the intervention group will be administered a creative drama exercise. Data will be collected using a Personal Information Form, the Breast Cancer Awareness Scale, and the Gynecological Cancer Awareness Scale.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being between the ages of 18-35,
  • Not having any health problems,
  • Agreeing to participate in the study,

Exclusion criteria

  • Students who are under 18 or over 35 years old.
  • Students who do not voluntarily agree to participate in the study will not be included in the study.

Treatment and study plan

Creative Drama Education

Other

This study is a pre-test/post-test controlled experimental design aimed at evaluating the effectiveness of creative drama education on awareness of breast and gynecological cancers.

Students in the intervention group will receive creative drama-based training structured and implemented by the researcher. This training is designed to increase awareness of breast and gynecological cancers.

The effectiveness of the training will be assessed by comparing participants' awareness levels before and after the intervention. For this purpose, the following data collection tools will be used:

Personal Information Form Breast Cancer Awareness Scale Gynecological Cancers Awareness Scale The impact of the creative drama education on the awareness levels of students in the intervention group regarding breast and gynecological cancers will be evaluated through statistical analysis.

Primary outcomes

  1. Personel Information Form

    Time frame: Baseline

    The researcher will prepare a form based on literature information and will question the students' sociodemographic characteristics.

  2. Gynecological Cancers Awareness Scale

    Time frame: Baseline and up to 4 weeks

    To assess women's knowledge levels about gynecological cancers, Dal and Ertem developed the Gynecological Cancer Awareness Scale (GCAAS) in 2017. The scale consists of 41 questions and four subscales. 10. The scale can only be applied to women. The Cronbach's alpha value of the scale is 0.944. Questions 20-41 of the scale determine "Awareness of Routine Check-up and Perception of Serious Illness in Gynecological Cancers," and the Cronbach's alpha value of this subscale is 0.979. Questions three through 11 of the scale determine "Awareness of Gynecological Cancer Risks," and the Cronbach's alpha value of this subscale is 0.843. Questions 14-19 of the scale determine "Awareness of Prevention of Gynecological Cancers," and the Cronbach's alpha value is 0.778. The first and second questions of the scale, as well as the 12th and 13th questions, determine "Early Diagnosis and Information Awareness in Gynecological Cancers," and the Cronbach's Alpha value is 0.708.

  3. Breast Cancer Awareness Scale

    Time frame: Baseline and up to 4 weeks

    The scale was developed by Rakkapao et al. (2016) for the early detection and prevention of breast cancer. It is easy to use and was designed as a self-report tool that allows researchers and practitioners to better understand women's breast cancer awareness levels. The original scale consists of five factors and 35 items. Adapted to our language by Altuntuğ et al. in 2021, the scale obtained a five-factor structure with 29 items. The subdimensions of the scale were found to have good internal consistency. The Cronbach's alpha internal consistency coefficients for the subdimensions of the scale were 0.87 for Knowledge of Risk Factors, 0.88 for Knowledge of Signs and Symptoms, 0.81 for Breast Cancer Prevention Attitudes, 0.78 for Barriers to Breast Screening, and 0.61 for Health Behavior Related to Breast Cancer Awareness.

Study contacts

Contact information is provided by the study sponsor or research team.

Sultan Esra SAYAR, Lecturer

CONTACT

[email protected]

+905302935474

Zülbiye DEMİR BARBAK, 1

CONTACT

[email protected]

+905435164229

Sponsors and collaborators

Lead sponsor

Ataturk University

Other

Registry information

Official study title

The Effect of Breast and Gynecological Cancer Education Using Creative Drama Method on Midwifery Students' Awareness: A Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Jul 18, 2025
Registry last updated
Jul 18, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.